| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 09/20/2006 | CN1836036A Proteases and methods for producing them |
| 09/20/2006 | CN1836035A Proteases and methods for producing them |
| 09/20/2006 | CN1835967A Viral polymerase and modulation thereof |
| 09/20/2006 | CN1834251A Fusion gene of beta-glucanase and xylanase, constitution method and application |
| 09/20/2006 | CN1834250A Fusion gene of beta-glucanase and xylanase, constitution method and application |
| 09/20/2006 | CN1834249A Fusion gene of beta-glucanase and xylanase, constitution method and application |
| 09/20/2006 | CN1834239A Prepn. process for freezing dry powder of bromelain |
| 09/20/2006 | CN1834238A Prepn. process of and use of thrombus dissolving enzyme |
| 09/20/2006 | CN1834237A Beta-mannase, its expression and special engineering bacterium |
| 09/20/2006 | CN1834236A Lipase A variant of wild Bacillus subtilis and application thereof |
| 09/20/2006 | CN1834222A Fetid aspergillic strain and uses |
| 09/20/2006 | CN1276075C Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same |
| 09/20/2006 | CN1275980C Method of modifying microorganism-origin transglutaminase |
| 09/19/2006 | US7109396 Preparing transgenic corn with increased concentrations of sulfur containing compounds for improving animal feeds and viability of maize |
| 09/19/2006 | US7109391 Plant farnesyltransferases |
| 09/19/2006 | US7109315 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 09/19/2006 | US7109310 Method and kit for detecting, or determining the quantity of, metabolites of fentanyl and metabolites of fentanyl analogs |
| 09/19/2006 | US7109291 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody |
| 09/19/2006 | US7109230 Resistance-repellent retroviral protease inhibitors |
| 09/19/2006 | US7109170 Tetra-, penta-, hexa-, hepta-, octa-, or nonapeptide capable of inhibiting the activation of blood-coagulation factor X in presence of coagulation factor VIIIa; polypeptide derived from helix 330 of blood coagulation factor IXa |
| 09/19/2006 | US7109162 Plant derived antioxidants |
| 09/19/2006 | US7109021 Can be used for the treatment of diabetes or for delaying the onset of diabetes |
| 09/19/2006 | US7109020 Leguminous bacterium having potentiated nitrogen fixation ability |
| 09/19/2006 | US7109018 Transformant producing secondary metabolite modified with functional group and novel biosynthesis genes |
| 09/19/2006 | US7109017 Antibodies having preferential binding to proteases; screening for enzyme inhibitors used in therapy of neurodegenerative diseases, such as Alzheimer's disease |
| 09/19/2006 | US7109016 Genetically engineered substilisin for use as degratory agent in cleaning or laundering detergent |
| 09/19/2006 | US7109015 Capable of removing the N-terminal Met from bulky or acidic penultimate residues |
| 09/19/2006 | US7109014 Diglycosidase isolated from microorganisms |
| 09/19/2006 | US7109013 Cellulase preparation containing nonionic surfactant and method of treating fiber |
| 09/19/2006 | US7109012 Recombinant lysophosphatidic acid phosphatase |
| 09/19/2006 | US7109011 Nucleotide sequences coding polypeptide for use in the treatment of infections, pneumonia, toxic shock, brain and rheumatic diseases |
| 09/19/2006 | US7109010 Isolated nucleic acid encoding a yeast lactate dehydrogenate protein; use in production of lactic acid |
| 09/19/2006 | US7109009 Comprises nucleotide sequences coding enzymatic polypeptide for producing intermediates associated with thermoplastics, plasticizing agents, lubricants, hydraulic fluids, dyes, agricultural hemicals, pharmaceuticals and adhesives |
| 09/19/2006 | US7109008 L-glutamate oxidase |
| 09/19/2006 | US7109007 Polyhydroxybutyrate polymerase |
| 09/19/2006 | US7109004 Process for reducing an alpha-keto ester |
| 09/19/2006 | US7108997 Identifying myeloperoxidase modulator via decrease in hypochlorous acid conversion into chloramine; for treating nervous system, atherosclerotic, cancer, respiratory and inflammatory disorders |
| 09/19/2006 | US7108994 Identifying a compound that modulates phosphotyrosine phosphatase activity of a polypeptide by incuabating togetjer and measuring activity of enzyme |
| 09/19/2006 | US7108987 Factors participating in degranulation of mast cells, DNAs encoding the same, method of screening of these factors and the inhibitors |
| 09/19/2006 | US7108975 Atlastin |
| 09/19/2006 | US7108854 Also an antibody which specifically binds to the protein and a Hybridoma cell line that produces the protein; immunoprophylactic uses |
| 09/19/2006 | US7108853 Surface protein of Leptospira |
| 09/19/2006 | CA2308117C Novel nucleic acid sequence encoding flp recombinase |
| 09/19/2006 | CA2235269C Monoclonal antibody br110 and uses thereof |
| 09/19/2006 | CA2149459C Acylated aminoalkanimidazoles and -triazoles |
| 09/19/2006 | CA2083396C Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them |
| 09/19/2006 | CA2074854C Imidazolinone resistant ahas mutants |
| 09/14/2006 | WO2006096834A2 Hydrolases, nucleic acids encoding them and methods for improving paper strength |
| 09/14/2006 | WO2006095769A1 Microorganism-derived psychrophilic endonuclease |
| 09/14/2006 | WO2006095731A1 CRYSTAL OF COMPLEX OF Rho-KINASE AND SUBSTANCE CAPABLE OF INTERACTING WITH Rho-KINASE |
| 09/14/2006 | WO2006094943A2 Acidophilic enzymes |
| 09/14/2006 | WO2006094791A1 Crystallographic structure of mnk-1 and mnk-2 proteins |
| 09/14/2006 | WO2006094673A2 Synergistic mixtures of c6- to c12-alkanedi0ls and tropolone (derivatives) |
| 09/14/2006 | WO2006094536A1 Targeted plasminogen activator fusion proteins as thrombolytic agents |
| 09/14/2006 | WO2006075142A3 FORMS OF FACTOR XIIa |
| 09/14/2006 | WO2006069812A3 Retrotransposon inhibition in therapy |
| 09/14/2006 | WO2006063300A3 Crystal structure of hepatocyte growth factor activator complexed with kunitz domain inhibitor |
| 09/14/2006 | WO2006060062A3 Trichoderma reesei glucoamylase and homologs thereof |
| 09/14/2006 | WO2006048458A3 Microbial strains producing sphingoid bases or derivatives thereof |
| 09/14/2006 | WO2006047589A3 Improved alanine 2,3-aminomutases and related polynucleotides |
| 09/14/2006 | WO2005117964A3 Cynomolgus prostate specific antigen |
| 09/14/2006 | WO2005103694A3 Methods and fish models for identifying agents for treating bone and joint disease |
| 09/14/2006 | WO2005089379A3 Antirotational structure for wave energy converters |
| 09/14/2006 | WO2005077091A8 Nicotinamide riboside kinase compositions and methods for using the same |
| 09/14/2006 | WO2005065418A3 Compositions and methods of use of targeting peptides for diagnosis and therapy |
| 09/14/2006 | WO2005046314A3 Tomatoes having altered acid invertase activity due to non-transgenic alterations in acid invertase genes |
| 09/14/2006 | WO2004050831A3 Compositions, organisms and methodologies employing a novel human kinase |
| 09/14/2006 | US20060206964 Method for enhancing cellulose and modifying lignin biosynthesis in plants |
| 09/14/2006 | US20060206963 Nucleic acid constructs and methods for producing altered seed oil compositions |
| 09/14/2006 | US20060206962 Preparation of deallergenized proteins and permuteins |
| 09/14/2006 | US20060206961 Use of genes for increasing the oil content in plants |
| 09/14/2006 | US20060206960 Higher plant cytosolic er-based glycerol-3-phosphate acyltransferase genes |
| 09/14/2006 | US20060206957 Converting farnesyl-pyrophosphate to patchoulol, gamma -curcumene and other germacrane-type sesquiterpenes; vectors; host cells |
| 09/14/2006 | US20060206949 Custom-made meganuclease and use thereof |
| 09/14/2006 | US20060205933 Pon polypeptides polynucleotides encoding same and compositions and methods utilizing same |
| 09/14/2006 | US20060205688 Method of modulating epithelial cell activity by modulating the functional levels of sphingosine kinase |
| 09/14/2006 | US20060205054 DNA encoding a Tumor Antigen Derived Gene-14 (TADG-14) protein which is overexpressed in ovarian, breast and colon carcinoma; for detecting and targeting of these carcinomas |
| 09/14/2006 | US20060205053 phosphatidyl-glycerolphosphate synthase; used to identify compounds that act as agonists and antagonists and modulate the expression of the novel PGP synthase; for drug screening |
| 09/14/2006 | US20060205052 Bardet-Biedl susceptibility gene and uses thereof |
| 09/14/2006 | US20060205046 Nucleotide sequences which code for the zwa1 gene |
| 09/14/2006 | US20060205045 Which produces N-alkyl-L-alanine from pyruvic acid and alkylamine or dialkylamine using NADPH and/or NADH as coenzyme; biosynthesis |
| 09/14/2006 | US20060205042 Novel variant hypocrea jecorina CBH2 cellulases |
| 09/14/2006 | US20060205041 Recombinant bovine thrombin |
| 09/14/2006 | US20060205036 Coagulation Factor VII polypeptides |
| 09/14/2006 | US20060205031 Newly identified cholinephosphotransferases and ethanolaminephosphotransferases |
| 09/14/2006 | US20060205030 Hydantoinase; carbamylases; nutraceuticals; animal feeds/husbandry |
| 09/14/2006 | US20060205021 Mammalian IAP gene family, primers, probes and detection methods |
| 09/14/2006 | US20060205018 Polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides; use in therapy |
| 09/14/2006 | US20060204994 Novel human protein kinases and protein kinase-like enzymes |
| 09/14/2006 | US20060204963 Nucleotide sequences of coryneform bacteria coding for proteins involved in l-serine metabolism and method for producing l-serine |
| 09/14/2006 | US20060204955 Method for the production of bacterial toxins |
| 09/14/2006 | US20060204490 Hemostatic compositions containing sterile thrombin |
| 09/14/2006 | US20060204489 Protein C derivatives |
| 09/14/2006 | US20060204487 Production of high mannose proteins in plant culture |
| 09/14/2006 | US20060204483 determining whether a target cell expresses telomerase reverse transcriptase (TRT) by combining human T lymphocytes ex vivo with antigen-presenting cells containing a polypeptide that comprises at least 8 consecutive amino acids of telomerase reverse transcriptase |
| 09/14/2006 | DE10244842B4 Für proteinspaltende Enzyme in Form von spezifischen Proteasen kodierende Nukleinsäuresequenzen, zugehörige Polypeptide und Verwendung von allen For protein-splitting enzymes in the form of specific proteases coding nucleic acid sequences associated polypeptides and use of all |
| 09/14/2006 | DE102005010804A1 Verfahren zur Herstellung optisch aktiver Alkohole A process for producing optically active alcohols |
| 09/14/2006 | CA2601472A1 Hydrolases, nucleic acids encoding them and methods for improving paper strength |
| 09/14/2006 | CA2601271A1 Targeted plasminogen activator fusion proteins as thrombolytic agents |
| 09/14/2006 | CA2600370A1 Bioactive fus1 peptides and nanoparticle-polypeptide complexes |